Benign Granular Cell Tumor of Interarytenoid Fold: A Case Report and Comprehensive Review in South Korea

Article information

J Korean Soc Laryngol Phoniatr Logop. 2024;35(2):70-74
Publication date (electronic) : 2024 August 30
doi : https://doi.org/10.22469/jkslp.2024.35.2.70
Department of Otolaryngology-Head and Neck Surgery, Dankook University College of Medicine, Cheonan, Korea
Corresponding Author Seung Hoon Woo, MD, PhD Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University College of Medicine, 201 Manghyang-ro, Dongnam-gu, Cheonan 31116, Korea Tel +82-41-550-1781 Fax +82-41-550-7837 E-mail lesaby@hanmail.net
Received 2024 June 10; Revised 2024 July 30; Accepted 2024 August 21.

Abstract

Granular cell tumor (GCT) is a extremely rare soft tissue tumor which can mimic the histopathology of squamous cell carcinoma (SCC). The character of GCT in larynx is usually benign but malignant change could be possible. Thus, it is important to distinguish laryngeal GCT from benign disease such as granuloma, polyp, not to mention malignant disease such as laryngeal SCC. The diagnosis is done by immunohistochemistry. Treatment for GCT is surgical removal with negative margin. Although systemic review of laryngeal GCT exists abroad, our literature made the first attempt to organize 13 cases in South Korea reported since 2002. We also present our case of patient with young age but with heavy smoking history in 2023 thereby contributing to cases of GCT of larynx reported in South Korea with possible correlation with smoking.

INTRODUCTION

Granular cell tumor (GCT) is a rare type of soft tissue tumor that accounts for approximately 0.5% of all soft tissue tumor [1]. Nearly half of GCT occur in head & neck, most commonly in tongue accounting 33%, but rarely in larynx accounting for 3%–10% [2]. GCT mimics squamous cell carcinoma (SCC) due to its histopathological characteristic of pseudoepitheliomatous hyperplasia [3]. Misdiagnosis can be prevented via immunohistoschemistry with the use of S-100 protein, neuron-specific enolase, vimentin, myelin-associated glycoprotein (Leu-7) and CD 68 (KP-1) [4-6]. Symptoms may present hoarseness, cough, stridor, hemoptysis, dysphagia, or even asymptomatic. Our clinical facility happened to encounter such rare case in 2023 as GCT in patient with chief complain of hoarseness, thereby report our case in this literature along with some comparisons with cases of GCT of larynx reported in South Korea.

CASE REPORT

A 24-year-old female patient visited our Head & Neck Clinic with chief complaint of hoarse voice and cough lasting for more than 6 months. The patient had no other symptoms. She was taking medicine for major depressive disorder. She was a 8 pack-year smoker and an alcoholic who drinks heavily more than 5 days a week. She had no other disease or past medical history. Laboratory blood test showed no specific abnormality. Physical examination was performed but there was no palpable mass in neck, and no specific findings grossly. Radiologic lung image showed no abnormality.

Examination with laryngoscope showed whitish, round mass about 0.2 cm in diameter (Fig. 1A). The mass was located on interarytenoid fold, slightly embedded. The margin was well circumscribed but not encapsulated. The mass grossly showed no invasion to the vocal cord. The vocal cord movement was intact with scanty amount of sputum near vocal cord and piriform sinus. There were both vocal cord nodules symmetrically. Storoboscopy showed impaired mucosal wave and incomplete glottis closure mainly due to both vocal nodules present at the anterior portion of true vocal cord. The patient showed posterior glottic swelling which suggested the possibility of larngopharyngeal reflux disease (LPRD). The patient was initially diagnosed with laryngeal mass with both vocal cord nodules with concurrent LPRD. Although endoscopic finding suggested benign lesion rather than malignant, patient wanted invasive and quick procedure due to non-resolving hoarse voice that lasted for more than 6 months. Microscopic surgery with biopsy was planned for treatment. Proton pump inhibitor was also prescribed for 2 months.

Fig. 1.

Suspension laryngoscopic view. Interarytenoid mass with whitish surface indicated with arrow. Postoperative 1 week follow-up laryngoscope (A). Postoperative 1 month laryngoscope (B). No recurrence occurred. Operative site indicated with arrow (C).

Under general anesthesia, microscopic examination of larynx with suspension laryngoscope was performed. Both vocal cord nodules and 0.2 cm×0.2 cm sized whitish mass on interarytenoid fold was identified. Both vocal cord nodules were excised with microscopic scissors. Mass was removed with monopolar instrument with resection margin of 2 mm. Frozen biopsy was performed only for the mass but was diagnosed with ‘non-diagnostic of carcinoma’. Histopathologic biopsy diagnosed both vocal cord specimen as ‘vocal cord nodules, bilateral’ and the mass on arytenoid was diagnosed with GCT with large polygonal cells with small nuclei and intensely eosinophilic granular cytoplasm (Fig. 2A). S-100 and CD68 stain was diffusely positive and Cytokeratin was negative (Fig. 2B).

Fig. 2.

Microphotograph of the tumor reveals sheets of large polygonal cells with small nuclei and intensely eosinophilic granular cytoplasm (original magnification ×200, hematoxylin-eosin stain) (A). S100 immunohistochemistry is diffusely and strongly positive in tumor cells (original magnification ×200, immunohistochemistry) (B).

One week after surgery the patient’s voice was improved and cough reduced as the result of tumor removal (Fig. 1B) After 1 month, the surgically removed arytenoid fold was well healing with no sign of recurrence (Fig. 1C). The patient had no recurrence during 2 months of follow-up and has not been visiting our clinic for more than 4 months.

DISCUSSION

GCT was first described by Russian pathologist Abrikossoff. It was initially named myoblastoma based on the thought that it was muscle originated [7]. Due to recent development of immunohistochemistry, it is mainly accepted that GCT is of schwann cell origin because it shows positive stain for S-100 protein & neuron-specific enolase and negative stain for muscle cell related markers [8,9]. However, some case reports proved that some GCTs are neuron-specific enolase negative [10-12]. Therefore, there remain still some controversies about where granular cell originate from.

For GCT in larynx, the most common symptom is hoarseness. Cough, dysphagia, stridor, hemoptysis, and even dyspnea could happen if the mass is big enough which is presented in case no. 12 with the largest GCT size among the Table 1. The most common location of GCT in larynx is known to be true vocal cord, followed by arytenoid, anterior commissure and false vocal folds [5]. Table 1 shows some features of benign GCT in larynx that were reported in South Korea from 2002. The most common location of GCT in South Korea was true vocal cords as well. Females and children were rarely reported.

Case reports of granular cell tumor of larynx in South Korea

Differential diagnosis include SCCs, papillomas, polyps, granulomas, cysts, neuromas, and neurofibromas, and lipoma [2]. Benign lesion such as papilloma, granuloma, polyp can be distinguished by their gross feature, but histological confirm is always important because they may look similar. Among the differential diagnosis, distinguishing SCC is of utmost importance. Gross morphology of GCT is nonencapsulated, well-circumscribed and small in size usually less than 2 cm [5]. Histologically, overlying pseudoepitheliomatous hyperplasia is the main histologic feature of GCT which can mislead to diagnosis of squamous cell cancer, but GCT can be differentiated with features such as lack of nuclear pleomorphism and presence of granular cell with immunohistochemistry stain. GCTs usually have polygonal or elongated cell with eosinophil granules and no mitotic figure. Immunohistochemistry for GCT is known to be positive for vimentin, S100, NSE and CD68 but negative for cytokeratin, actin (smooth muscle), desmin, GFAP, EMA, CD34, HMB45 and NF-LH [1]. Ki-67 which is positively presented by SCC does not usually show positivity in GCT, however positive expression of Ki-67 in GCT may suggest malignant granular cell tumor (MGCT) [3]. Our patient’s result was positive for S-100 & CD68 but negative for multiple cytokeratin which was typical result for benign GCT.

The generally accepted treatment of choice for benign granular cell tumor of larynx is surgical excision. The recurrence rate of surgically removed laryngeal GCT is 2%–3% if completely removed. Checking frozen section is recommended to secure negative resection margin. When surgical margins are positive, the recurrence rate is reported up to 50%. Case no.5 who went through microscopic resection was later found with recurrence within 4 months but after re-excision with laser, no recurrence was reported [13]. Most cases in Korea (Table 1) used suspension laryngoscope with CO2 laser. The surgical extent is based on location and the size of the tumor, so if the mass is large, laryngofissure or partial laryngectomy may be the appropriate choice [2].

MGCT account for only 2% of GCT with metastasis most commonly to lungs, liver and bones [14]. Radiation therapy and chemotherapy are not considered effective for MGCT, and there is no consensus on using chemoradiation for these patients. However there exists a case report of successful use of pazopanib in patient with orbital MGCT [15]. MGCT in larynx has not been reported yet in South Korea, thus not listed on the Table 1.

Our patient was young female, rare compared to cases in Korea where mostly male patients were reported. Among 13 patient listed in the Table 1 only 2 patient were females. Our patient smoked 2 pack of cigarettes everyday for 4 consecutive years. According to this Table 1, 6 patients were indicated with smoking history. The size of tumor and pack-year amount of smoking does not seem to correspond according to the Table 1, yet there are limitation of small number of patients in Korea to hypothesize such correlation. Since smoking is known predisposing risk factor for SCC of larynx, it is important to distinguish the 2 diseases in heavy smokers so that appropriate treatment could be done. In case of GCT, surgical removal with negative margin rather than chemoradiation should be performed. Our patient was too young to consider SCC. However, confirming diagnosis with immunohistochemistry should be considered most important in GCT of larynx. When considering age on the Table 1, 6-year-old patient was the youngest and 63-year-old patient was oldest. Also, 10 patients among 13 patients were less than 50-year-old including 3 patients who are not adults. This may suggest that unlike SCC, GCT is not necessarily correlated with old age. Although small in number of patient which is difficult to derive statistically significant results, our literature made the first attempt to organize rare cases of GCT of larynx reported in Korea with features such as age, sex, size, symptoms, location, recurrence and relation with smoking. The result was high prevalence in male, true vocal cord as most common lesion, variable size usually smaller than 2 cm, most case with no recurrence with surgical removal, and relatively young age. Further collection of cases with GCT patients may be studied in the future for more statistical analysis in South Korea.

Supplementary Materials

The online-only Data Supplement is available with this article at https://doi.org/10.22469/jkslp.2024.35.2.70.

Acknowledgements

None

Notes

Ethics Statement

This study was approved from Institutional Review Board of Dankook University Hospital (DKUH 2024-03-006). Informed consent was exempted from IRB due to the retrospective design.

Funding Statement

This research was supported and funded by SNUH Lee Kun-hee Child Cancer & Rare Disease Project, Republic of Korea (grant number: 23C-023-0100).

Conflicts of Interest

The authors have no financial conflicts of interest.

Authors’ Contribution

Conceptualization: Seung Hoon Woo. Data curation: Min Seok Moon. Formal analysis: Seung Hoon Woo, Min Seok Moon. Funding acquisition: Seung Hoon Woo. Investigation: Seung Hoon Woo, Min Seok Moon. Methodology: Seung Hoon Woo, Min Seok Moon. Project administration: Seung Hoon Woo. Resources: Seung Hoon Woo. Software: Min Seok Moon. Supervision: Seung Hoon Woo. Validation: Seung Hoon Woo, Min Seok Moon. Visualization: Min Seok Moon. Writing—original draft: Min Seok Moon. Writing—review & editing:Seung Hoon Woo, Min Seok Moon. Approval of final manuscript: Seung Hoon Woo, Min Seok Moon.

References

1. Liu TT, Han Y, Zheng S, Li B, Liu YQ, Chen YX, et al. Primary cutaneous malignant granular cell tumor: a case report in China and review of the literature. Diagn Pathol 2015;10:113.
2. Hwang I, Hwang JE, Choi SH, Nam SY, Cho KJ. Granular cell tumors of the larynx. Korean J Pathol 2007;41(4):284–7.
3. Ferreira JC, Oton-Leite AF, Guidi R, Mendonça EF. Granular cell tumor mimicking a squamous cell carcinoma of the tongue: a case report. BMC Res Notes 2017;10(1):14.
4. Arevalo C, Maly B, Eliashar R, Gross M. Laryngeal granular cell tumor. J Voice 2008;22(3):339–42.
5. Park JH, Do NY, Cho SI, Choi JY. Granular cell tumor on larynx. Clin Exp Otorhinolaryngol 2010;3(1):52–5.
6. Sobel HJ, Marquet E. Granular cells and granular cell lesions. Pathol Annu 1974;9:43–79.
7. Abrikossoff A. [Über myome: ausgehend von der quergestreiften willkürlichen muskulatur]. Virchows Arch Path Anat 1926;260:215–33. German.
8. Fisher ER, Wechsler H. Granular cell myoblastoma—a misnomer. Electron microscopic and histochemical evidence concerning its Schwann cell derivation and nature (granular cell schwannoma). Cancer 1962;15(5):936–54.
9. Rekhi B, Jambhekar NA. Morphologic spectrum, immunohistochemical analysis, and clinical features of a series of granular cell tumors of soft tissues: a study from a tertiary referral cancer center. Ann Diagn Pathol 2010;14(3):162–7.
10. Fernandez-Flores A, Cassarino DS, Riveiro-Falkenbach E, Rodriguez-Peralto JL, Fernandez-Figueras MT, Monteagudo C. Cutaneous dermal non-neural granular cell tumor is a granular cell dermal root sheath fibroma. J Cutan Pathol 2017;44(6):582–7.
11. Lazar AJ, Fletcher CD. Primitive nonneural granular cell tumors of skin: clinicopathologic analysis of 13 cases. Am J Surg Pathol 2005;29(7):927–34.
12. Lewin MR, Montgomery EA, Barrett TL. New or unusual dermatopathology tumors: a review. J Cutan Pathol 2011;38(9):689–96.
13. Cho SH, Park KS, Woo JS, Jung KY. [A case of granular cell tumor of the larynx]. Korean J Otorhinolaryngol-Head Neck Surg 2002;45(11):1114–7. Korean.
14. Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol 1998;22(7):779–94.
15. Morita S, Hiramatsu M, Sugishita M, Gyawali B, Shibata T, Shimokata T, et al. Pazopanib monotherapy in a patient with a malignant granular cell tumor originating from the right orbit: a case report. Oncol Lett 2015;10(2):972–4.

Article information Continued

Fig. 1.

Suspension laryngoscopic view. Interarytenoid mass with whitish surface indicated with arrow. Postoperative 1 week follow-up laryngoscope (A). Postoperative 1 month laryngoscope (B). No recurrence occurred. Operative site indicated with arrow (C).

Fig. 2.

Microphotograph of the tumor reveals sheets of large polygonal cells with small nuclei and intensely eosinophilic granular cytoplasm (original magnification ×200, hematoxylin-eosin stain) (A). S100 immunohistochemistry is diffusely and strongly positive in tumor cells (original magnification ×200, immunohistochemistry) (B).

Table 1.

Case reports of granular cell tumor of larynx in South Korea

No. Author Year Sex Age Symptom Tumor location Size Treatment Recurrence reported Smoking
1 Park et al. [1] 2010 M 60 Hoarseness R) True vocal cord 0.5×0.3 cm Resection with laser No recurrence 1 yr Not indicated
2 Hwang et al. [2] 2007 M 37 Hoarseness, FB sensation in throat L) True vocal cord 0.4×0.3 cm Resection with laser No recurrence 6 months 40 pack-years
3 Hwang et al. [2] 2007 M 63 Voice change R) True vocal cord 0.2×0.2 cm Resection with laser No recurrence 3 months 20 pack-years
4 Hwang et al. [2] 2007 M 45 Hoarseness L) Arytenoid 0.4×0.3 cm Endoscopic removal No recurrence 2 months 45 pack-years
5 Cho et al. [3] 2002 M 33 Hoarseness L) True vocal cord 0.7×0.5 cm Microscopic resection Recurrence 4 months 18 pack-years
6 Lee et al. [4] 2018 M 40 No symptom L) False cord 2×2 cm Resection with laser Not indicated Not indicated
7 Jin et al. [5] 2006 M 41 Hoarseness, FB sensation in throat L) True vocal cord 0.3×0.3 cm Microscopic resection No recurrence 3 months 20 pack-years
8 Oh et al. [6] 2008 F 14 FB sensation in throat Epiglottis 0.8×0.7 cm Resection with laser No recurrence 20 months Not indicated
9 Choi et al. [7] 2002 M 16 Hoarseness, FB sensation in throat R) True vocal cord 0.2×0.2 cm Microscopic resection No recurrence 2 months Not indicated
10 Sun et al. [8] 2005 M 62 No symptom L) Arytenoid 1×0.7 cm Resection with laser No recurrence 4 months Not indicated
11 Lee [9] 2022 M 30 Voice change L) Vocal process 0.3×0.3 cm Resection with laser No recurrence 6 months Not indicated
12 Oh et al. [10] 2020 M 6 Wheezing, dyspnea Posterior glottis 2.1×0.9 cm Resection with laser No recurrence 1 yr Not indicated
13 Woo [11] 2023 F 24 Hoarseness, cough Interarytenoid fold 0.2×0.2 cm Microscopic resection No recurrence 2 months 8 pack-years

The references in the table can be found in the Supplement Material (in the online only).